Travere Therapeutics, Inc. ( TVTX) - Stock Earnings
TVTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 29, 2026, midnight | — / — | — | — / — | — |
TVTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 2.7 million USD | 129.7 million USD |
| 2026Q1 | -37.1 million USD | 127.2 million USD |
| 2026Q2 | -34.8 million USD | 169.6 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TVTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -111.4 million USD | 145.2 million USD |
| 2024 | -321.5 million USD | 233.2 million USD |
| 2025 | -25.5 million USD | 490.7 million USD |
| 2026 Est. | — | — |
TVTX
Price: $52.79
52 week price:
Earnings Per Share: -0.72 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Market Capitalization: 5.3 billion